Effect of deferoxamine administration on the treatment of iron accumulation-induced osteopenia in male mice
Lulin LIU,Xiao WANG,Guangfei LI,Cao GAO,Chen YU,Guangsi SHENG,Peng ZHANG,Mingxia WU,Aidong WANG,Huang Xi,Youjia XU
DOI: https://doi.org/10.3969/j.issn.1006-7108.2015.01.020
2015-01-01
Abstract:Objective To explore the therapeutic effect of deferoxamine on iron accumulation?induced osteopenia and to understanditsmechanismofaction.Methods Thirty?two2-month?oldmaleICRmicewererandomlydividedinto4groups(n=8, in each). Group A (control) received normal saline. Group B, C, and D received intraperitoneal ferric ammonium citrate (FAC) injection of for 2 months. After 2?month intervention, group A and B were sacrificed. Group C and D received intraperitoneal injection of normal saline or DFO for another month, and then sacrificed. Serum iron, calcium, phosphorus, type I collagen C?terminal peptide (CTX), tartrate?resistant acid phosphatase 5b (TRAP?5b), osteocalcin (BGP), superoxide dismutase (SOD), malondialdehyde( MDA) , liver iron content, and liver iron particle Peals’ staining were determined. The cancellous bone of the left femur scanned and analyzedusingmicro?CTand3Dreconstruction.Results (1)SerumandliverironcontentmeasurementaswellasliverPeals’ staining showed a significant increase in group B than in group A, indicating the success of the iron accumulation model. The iron related indices decreased significantly after DFO treatment in group D. (2) CTX and TRAP?5b in group B were significantly higher than in group A, but BGP was lower than in group A. CTX and TRAP-5b in group D was lower than in group C, but BGP was higher in group D than in group C, indicating DFO reversed partially the increase of bone resorption and inhibition of bone formation due to iron accumulation. (3) Serum oxidative stress makers MDA was higher in group B than in group A, but SOD was lower than in group A. MDA decreased but SOD increased in group D compared to group C. (4) Micro?CT demonstrated that compared with group A, group B showed decresed cancellous bone parameters. After one month intervention, bone parameters improved in group D comparing to group B. Conclusion The administration of DFO can reverse partially the increase of bone resorption and inhibition of bone formation due to iron accumulation, therefore increase BMD and improve bone microarchitecture. The mechanism may be associated with the modulateion of oxidative stress.